European IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.1% during the forecast period. Europe consists of numerous key economies including the UK, Germany, France, Spain, Italy, and others which register a significant share in the market. The changing lifestyle and significant share of the population which engages in smoking is also one of the key reasons which are expected to increase the prevalence of IBD in the region. The European Federation of Crohn's & Ulcerative Colitis Associations is one such organization in the region which engages in the monitoring of IBD in the region and conducting clinical studies so as to develop efficient treatment alternative for IBD. Furthermore, the prevalence of IBD increases with a change in eating patterns and unhealthy eating and smoking practices. It is observed that smoking is one of the key reasons which promotes the prevalence of IBD in the working-age population.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/european-ibd-inflammatory-bowel-disease-therapeutics-market

European IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. For Crohn’s and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A Full Report of European Inflammatory Bowel Disease (IBD) Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/european-ibd-inflammatory-bowel-disease-therapeutics-market

The companies which are contributing to the growth of the European IBD therapeutics market include AbbVie Inc., Allergan, PLC, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Johnson & Johnson Services Inc., Pfizer Inc., Pharmacosmos A/S, Sanofi S.A., and others.

Market Segmentation

European IBD THERAPEUTICS Market by Disease Type

Ulcerative Colitis
Crohn’s Disease

European IBD THERAPEUTICS Market by Treatment Type

Surgery
Anti- Inflammatory Drug Administration
Steroids
Immunosuppressant
Biological Drugs
Amino salicylates
Others

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-ibd-inflammatory-bowel-disease-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404